86 related articles for article (PubMed ID: 19396015)
1. Association of a single nucleotide polymorphic variation in the human chromosome 19q13.3 with drug responses in the NCI60 cell lines.
Nissen KK; Vogel U; Nexø BA
Anticancer Drugs; 2009 Mar; 20(3):174-8. PubMed ID: 19396015
[TBL] [Abstract][Full Text] [Related]
2. The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem cell support: a linkage disequilibrium mapping in RAI and CD3EAP.
Vangsted AJ; Klausen TW; Gimsing P; Abildgaard N; Andersen NF; Gregersen H; Nexø BA; Vogel UB
Ann Hematol; 2011 Jun; 90(6):675-84. PubMed ID: 21046104
[TBL] [Abstract][Full Text] [Related]
3. A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55.
Nexø BA; Vogel U; Olsen A; Ketelsen T; Bukowy Z; Thomsen BL; Wallin H; Overvad K; Tjønneland A
Carcinogenesis; 2003 May; 24(5):899-904. PubMed ID: 12771034
[TBL] [Abstract][Full Text] [Related]
4. Effects of polymorphisms in ERCC1, ASE-1 and RAI on the risk of colorectal carcinomas and adenomas: a case control study.
Skjelbred CF; Saebø M; Nexø BA; Wallin H; Hansteen IL; Vogel U; Kure EH
BMC Cancer; 2006 Jul; 6():175. PubMed ID: 16817948
[TBL] [Abstract][Full Text] [Related]
5. Different splicing isoforms of ERCC1 affect the expression of its overlapping genes CD3EAP and PPP1R13L, and indicate a potential application in non-small cell lung cancer treatment.
Zhang G; Xue P; Cui S; Yu T; Xiao M; Zhang Q; Cai Y; Jin C; Yang J; Wu S; Lu X
Int J Oncol; 2018 Jun; 52(6):2155-2165. PubMed ID: 29620255
[TBL] [Abstract][Full Text] [Related]
6. Multiple single nucleotide polymorphisms on human chromosome 19q13.2-3 associate with risk of Basal cell carcinoma.
Yin J; Rockenbauer E; Hedayati M; Jacobsen NR; Vogel U; Grossman L; Bolund L; Nexø BA
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1449-53. PubMed ID: 12433725
[TBL] [Abstract][Full Text] [Related]
7. Association of chromosome 19q13.2-3 haplotypes with basal cell carcinoma: tentative delineation of an involved region using data for single nucleotide polymorphisms in two cohorts.
Rockenbauer E; Bendixen MH; Bukowy Z; Yin J; Jacobsen NR; Hedayati M; Vogel U; Grossman L; Bolund L; Nexø BA
Carcinogenesis; 2002 Jul; 23(7):1149-53. PubMed ID: 12117772
[TBL] [Abstract][Full Text] [Related]
8. Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI-60 panel.
Le Morvan V; Bellott R; Moisan F; Mathoulin-Pélissier S; Bonnet J; Robert J
Pharmacogenomics; 2006 Sep; 7(6):843-52. PubMed ID: 16981845
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the genes ERCC2, XRCC3 and CD3EAP influence treatment outcome in multiple myeloma patients undergoing autologous bone marrow transplantation.
Vangsted A; Gimsing P; Klausen TW; Nexø BA; Wallin H; Andersen P; Hokland P; Lillevang ST; Vogel U
Int J Cancer; 2007 Mar; 120(5):1036-45. PubMed ID: 17131345
[TBL] [Abstract][Full Text] [Related]
10. Haplotypes of nine single nucleotide polymorphisms on chromosome 19q13.2-3 associated with susceptibility of lung cancer in a Chinese population.
Yin J; Vogel U; Ma Y; Qi R; Wang H
Mutat Res; 2008 May; 641(1-2):12-8. PubMed ID: 18358500
[TBL] [Abstract][Full Text] [Related]
11. p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13.3 that is reportedly deleted in some gliomas.
Tikoo A; Czekay S; Viars C; White S; Heath JK; Arden K; Maruta H
Gene; 2000 Oct; 257(1):23-31. PubMed ID: 11054565
[TBL] [Abstract][Full Text] [Related]
12. ERCC5 promoter polymorphisms at -763 and +25 predict the response to oxaliplatin-based chemotherapy in patients with advanced colorectal cancer.
Chen J; Xie F; Chen K; Wang D; Jiang H; Li J; Pan F; Chen S; Zhang Y; Ruan Z; Huang H; Zou L; Liang H
Cancer Biol Ther; 2009 Jul; 8(14):1424-30. PubMed ID: 19458483
[TBL] [Abstract][Full Text] [Related]
13. ATB(0)/SLC1A5 gene. Fine localisation and exclusion of association with the intestinal phenotype of cystic fibrosis.
Larriba S; Sumoy L; Ramos MD; Giménez J; Estivill X; Casals T; Nunes V
Eur J Hum Genet; 2001 Nov; 9(11):860-6. PubMed ID: 11781704
[TBL] [Abstract][Full Text] [Related]
14. Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR.
Tsang WP; Wong TW; Cheung AH; Co CN; Kwok TT
RNA; 2007 Jun; 13(6):890-8. PubMed ID: 17416635
[TBL] [Abstract][Full Text] [Related]
15. Genetic Polymorphisms in XRCC1, CD3EAP, PPP1R13L, XPB, XPC, and XPF and the Risk of Chronic Benzene Poisoning in a Chinese Occupational Population.
Xue P; Gao L; Xiao S; Zhang G; Xiao M; Zhang Q; Zheng X; Cai Y; Jin C; Yang J; Wu S; Lu X
PLoS One; 2015; 10(12):e0144458. PubMed ID: 26681190
[TBL] [Abstract][Full Text] [Related]
16. Mapping of human interferon regulatory factor 3 (IRF3) to chromosome 19q13.3-13.4 by an intragenic polymorphic marker.
Bellingham J; Gregory-Evans K; Gregory-Evans CY
Ann Hum Genet; 1998 May; 62(Pt 3):231-4. PubMed ID: 9803267
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between XRCC2 and XRCC5 single nucleotide polymorphisms and drug-sensitivity of human lung cancer cells].
Wang R; Wang W; Zhang JW
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(43):3059-62. PubMed ID: 19192406
[TBL] [Abstract][Full Text] [Related]
18. NDRG1 disruption alleviates cisplatin/sodium glycididazole-induced DNA damage response and apoptosis in ERCC1-defective lung cancer cells.
He L; Liu K; Wang X; Chen H; Zhou J; Wu X; Liu T; Yang Y; Yang X; Cui D; Song G; Wang J; Lei J
Int J Biochem Cell Biol; 2018 Jul; 100():54-60. PubMed ID: 29768183
[TBL] [Abstract][Full Text] [Related]
19. GLTSCR1, ATM, PPP1R13L and CD3EAP Genetic Variants and Lung Cancer Risk in a Chinese Population.
Yin JY; Ma YG; Vogel U; Liu DH; Sun ZX
Curr Med Sci; 2018 Aug; 38(4):734-740. PubMed ID: 30128886
[TBL] [Abstract][Full Text] [Related]
20. Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer.
Miwa W; Yasuda J; Murakami Y; Yashima K; Sugano K; Sekine T; Kono A; Egawa S; Yamaguchi K; Hayashizaki Y; Sekiya T
Biochem Biophys Res Commun; 1996 Aug; 225(3):968-74. PubMed ID: 8780719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
